Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zeng Zhang"'
Autor:
Ping Zhou, Hongjie Yang, Haohui Liang, Yilong Teng, Liping Jiang, Yanna Pan, Jiaqi Li, Zeng Zhang, Yanming He, Shilin Yuan, Xiao Wu
Publikováno v:
Oncology Letters. 21
The Traditional Chinese Medicine, Ganoderma lucidum, has been widely used for its immunity-related and anti-cancer effects. Fudan-Yueyang-Ganoderma lucidum (FYGL) is a proteoglycan, extracted from Ganoderma lucidum, that has shown safe anti-diabetic
Autor:
Xiao, Wu, Liping, Jiang, Zeng, Zhang, Yanming, He, Yilong, Teng, Jiaqi, Li, Shilin, Yuan, Yanna, Pan, Haohui, Liang, Hongjie, Yang, Ping, Zhou
Publikováno v:
Oncology Letters
The Traditional Chinese Medicine, Ganoderma lucidum, has been widely used for its immunity-related and anti-cancer effects. Fudan-Yueyang-Ganoderma lucidum (FYGL) is a proteoglycan, extracted from Ganoderma lucidum, that has shown safe anti-diabetic
Autor:
LU JIN1,2,3, ZENG ZHANG1,2,3, YIFAN LI1,2,3, TAO HE1,3,4, JIA HU1,3,5, JIAJU LIU1,3,6, MINGWEI CHEN2,3, YAOTING GUI3, YUN CHEN6 cyun126@126.com, YONGQING LAI1,3 yqlord@163.com
Publikováno v:
Oncology Letters. Jun2017, Vol. 13 Issue 6, p4512-4520. 9p.
Autor:
Zeng Zhang, Jia Hu, Yaoting Gui, Jiaju Liu, Xiangming Mao, Tao He, Lu Jin, Yongqing Lai, Yun Chen, Yifan Li, Mingwei Chen, Shangqi Yang
Publikováno v:
Oncology Letters.
Renal cell carcinoma (RCC) is the most common type of kidney cancer, and the prognosis of metastatic RCC remains poor with a high rate of recurrence and mortality. A previous study has revealed that microRNA (miRNA), which negatively regulates protei
Autor:
Jia Hu, Jiaju Liu, Zeng Zhang, Lu Jin, Yaoting Gui, Yifan Li, Mingwei Chen, Tao He, Yongqing Lai, Yun Chen
Publikováno v:
Oncology letters. 13(6)
MicroRNA (miR)-125b has been identified as deregulated in a number of types of cancer. Previous studies have detected the expression of miR-125b in clear cell renal cell carcinoma (ccRCC) tissues by in situ hybridization and revealed that miR-125b wa
Autor:
LU JIN, YIFAN LI, ZENG ZHANG, TAO HE, JIA HU, JIAJU LIU, MINGWEI CHEN, YAOTING GUI, SHANGQI YANG, XIANGMING MAO, YUN CHEN, YONGQING LAI
Publikováno v:
Oncology Letters; Nov2017, Vol. 14 Issue 5, p5624-5630, 7p